2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis.
Saved in:
| Title: | 2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis. |
|---|---|
| Authors: | Liu N; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Ma YR; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China., Pang JN; Department of Hematology, The First Hospital of Jilin University, Changchun, China., Sun M-; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China., Sun Y; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Liu YJ; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Hu JW; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Li YH; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Qiao ZQ; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China., Duan MH; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. mhduan@sina.com., Gao SJ; Department of Hematology, The First Hospital of Jilin University, Changchun, China. sjgao@jlu.edu.cn., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China. jiangqian@medmail.com.cn., Hu LD; Senior Department of Hematology, Chinese PLA General Hospital, Beijng, China, Beijng, China. huliangding@sohu.com. |
| Source: | Annals of hematology [Ann Hematol] 2026 Mar 23; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-026-06913-5 |
